Dialysis patient Brian Pinker received jab at Oxford’s Churchill hospital on Monday morning
India has approved the COVID-19 vaccine developed by AstraZeneca and Oxford University, paving the way for a huge immunisation campaign in the world’s second most populous country.
The Oxford-AstraZeneca vaccine has been approved for use in the UK, with the first doses due to be given on Monday amid rising coronavirus cases.
The UK has ordered 100 million doses - enough to vaccinate 50 million people.
AstraZeneca chief executive, Pascal Soriot, told the Sunday Times more tests were needed to be sure, but hailed the discovery of what he called a “winning formula” to improve the vaccine’s efficacy.
Share price drops as critics question claim vaccine could protect up to 90% of people
Oxford AstraZeneca Covid vaccine has up to 90% efficacy, data reveals
AstraZeneca and Oxford University’s potential COVID-19 vaccine produced a strong immune response in older adults, data published on Thursday showed, with researchers expecting to release late-stage trial results by Christmas.
"The UK committee has concluded its investigations and recommended to the MHRA that trials in the UK are safe to resume", the company said on Saturday.